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CHANGES IN T CELL METABOLISM IN POST-CARDIAC ARREST PATIENTS 
MEREDITH ALDEN HURLEY 
ABSTRACT 	  
Objective:  The survival rates for cardiac arrest patients to hospital discharge 
are very low.  Post-arrest patients have an immune response and usually a 
period of immunosuppression.  When CD3+ T cells activate, they switch from 
primarily relying on aerobic metabolism to primarily relying on anaerobic 
metabolism.  The goal of this study is to characterize the immune system of post-
cardiac arrest patients.  The specific objectives are (1) to determine the time 
period after the occurrence of a cardiac arrest that a patient acquires an 
infection, (2) to identify the most common types of infections in post-arrest 
patients, (3) to compare in vitro the cellular oxygen consumption of immune cells 
post-cardiac arrest with healthy controls, and (4) to compare cell proliferation and 
ATP production of immune cells post-cardiac arrest with healthy controls. 
Methods:  We conducted a retrospective chart review of 170 cardiac arrest 
patients (Beth Israel Deaconess Medical Center) who had return of spontaneous 
circulation.  We measured oxygen consumption rates of peripheral blood 
mononuclear cells (PBMCs) in cardiac arrest patients and healthy controls.  We 
also measured cell proliferation and ATP production of CD3+ T cells in cardiac 
arrest patients and healthy controls. 
	  	   v 
Results:  Of the 170 cardiac arrest patients we reviewed, 42% had at least one 
incidence of infection.  The length of time from cardiac arrest to first positive 
culture was 4 days, with pneumonia and urinary tract infections the most 
common diagnoses.  The PBMCs of cardiac arrest patients showed a significant 
decrease in oxygen consumption post arrest compared with healthy controls.  
When thiamine was added to the PBMC samples of cardiac arrest patients, there 
was a significant increase in oxygen consumption from baseline.  There was no 
significant difference in cell proliferation or ATP production of CD3+ T cells 
between the two groups of post-cardiac arrest patients and healthy controls. 
Conclusion:  Many patients suffer from infections post-cardiac arrest, and future 
research is needed on this subject.  Our data support the hypothesis that post-
arrest patients have a period of hyperimmune response followed by a period of 
immunosuppression. 
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INTRODUCTION 
 
 In 2013 there were 359,400 out-of-hospital cardiac arrests with a 9.5% 
survival-to-discharge rate as well as 209,000 in-hospital cardiac arrests with a 
23.9% survival-to-discharge rate for adults (Cardiac Arrest Statistics, 2014). The 
in-hospital mortality rate for patients who regained spontaneous circulation post-
cardiac arrest was between 67% and 71%.  This statistic has not changed 
appreciably over the last fifty years (Neumar et al., 2008).  
 Cardiac arrest causes whole-body ischemia and reperfusion and results in 
the most severe state of shock (Zhang et al., 2014).  During a cardiac arrest, the 
delivery of oxygen and nutrients to the body is quickly stopped (Zhang et al., 
2014).  This results in post-cardiac arrest syndrome (Gu et al., 2014).  After a 
cardiac arrest, there is an increase in cytokine release which leads to cytokine 
production dysregulation, including cytokines that activate the immune system 
(Zhang et al., 2014).  This situation is due to hemodynamic and cardiovascular 
function disorders which commonly occur after return of spontaneous circulation 
(Zhang et al., 2014).  Immunologic pathways are activated, and there is systemic 
inflammation as a result of the oxygen debt created by the cardiac arrest (Zhang 
et al., 2014).  The generalized activation of the immune systems leads to multiple 
organ dysfunction (Gu et al., 2013).  Adrie et al. (2002) studied post-cardiac 
arrest patients and showed that days after the hyperimmune response post-
cardiac arrest, patients experience a period of immunosuppression, and their 
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condition rapidly declines.  Adrie and coworkers attributed the period of 
immunosuppression to the increase of T cell activity immediately following the 
arrest.  Many cardiac arrest patients do not survive to hospital discharge because 
of sepsis and multiorgan failure (Gu et al., 2014).   
 It is important to note that the immune response has been shown to be the 
same in patients therapeutically cooled to 33 °C and 36 °C, suggesting that 
therapeutic hypothermia does not affect the immune response (Beurskens et al., 
2014). 
 
T Cells 
T cells participate in the body’s cellular adaptive immune response by 
directing or regulating immune response or by directly attacking another cell 
(Andersen et al, 2006; Immune System T Cells, 2008).  T cells have receptors on 
their surface that recognize antigens on infected cells (Immune System T Cells, 
2008).   
Immature T lymphocytes are produced in bone marrow and move to the 
thymus to mature.  In the thymus, the stromal cells, cytokines, and chemokines 
produce functional T cells from the immature T cells.  CD4+ and CD8+ are first 
found on the surface of the T cells in the thymus (Luckheeram et al, 2012).  
Mature T cells leave the thymus and go to secondary lymphoid organs including 
lymph nodes and spleen for further differentiation (Luckheeram et al, 2012).  
Before activation, these naïve T cells undergo aerobic metabolism by oxidative 
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phosphorylation to produce a surplus of ATP by catabolism of glucose, amino 
acids, and lipids (Delmastro-Greenwood and Piganelli, 2013).  Naïve T cells 
need a surplus of adenosine triphosphate (ATP) so they can quickly activate 
when needed (Delmastro-Greenwood and Piganelli, 2013). Naïve T cell 
metabolism is regulated by trophic signals rather than the available nutrients, and 
the quiescent state is actively maintained by cytokine signaling (Verbist et al., 
2012).  In this state, naïve T cells undergo homeostatic proliferation and have low 
rates of metabolism (Cao et al., 2014). 
During the innate immune response, the infection causes antigen-
presenting cells (APCs) to mature (Alberts, 2002).  The foreign antigen is 
detected, and APCs drain to the secondary lymphoid organs (Delmastro-
Greenwood and Piganelli, 2013).  APCs then process the antigen and present it 
to the lymphocytes, which activate in the secondary lymphoid organs and further 
differentiate into subsets of effector T cells like helper Th1 cells (Alberts, 2002; 
Delmastro-Greenwood and Piganelli, 2013).   
During the first 24 hours of activation, T cells enlarge in size, and then 
every 4 to 6 hours afterward, they divide.  Once they have divided, they 
differentiate into effector cells.  Effector T cells produce cytokines and release 
cytotoxic granules (Delmastro-Greenwood and Piganelli, 2013).  Early in 
activation, T cell metabolism changes from primarily relying on aerobic oxidative 
phosphorylation to primarily relying on a highly glycolytic metabolism (Cao et al., 
2014).  There is also an increase in oxidative phosphorylation, and some oxygen 
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consumption still occurs (Cao et al., 2014; Delmastro-Greenwood and Piganelli, 
2013).  After activation, T cells migrate to the site of infection by going through 
the endothelial wall and away from their source of oxygen (Delmastro-
Greenwood and Piganelli, 2013).  Change in environment is not the only factor 
that controls the change in T cell metabolism once activated (Delmastro-
Greenwood and Piganelli, 2013). Activated T cells use aerobic glycolysis 
(glycolysis in the presence of oxygen) because it is a hundred times faster in 
producing macromolecules and proliferating than oxidative phosphorylation.  The 
ability to quickly produce macromolecules is crucial in the elimination of 
pathogens in the body (Delmastro-Greenwood and Piganelli, 2013).  These 
metabolic changes are possible because there is an increase of expression of 
metabolic transporters, including glucose transporter 1 (GLUT1), which leads to 
an increase in glycolytic influx and glycolytic enzymes (Cao et al., 2014; 
Delmastro-Greenwood and Piganelli, 2013).  The increase of GLUT1 
transporters on the T cell surfaces has been shown to directly shift the 
metabolism from mostly oxidative phosphorylation to primarily glycolysis 
(Delmastro-Greenwood and Piganelli, 2013). 
T cells utilize glycolysis when they are activated.  After the pathogen has 
been cleared, the effector T cells have a diminished mitochondrial mass and can 
only survive by using glycolysis.  These T cells will undergo apoptosis because 
they do not have adequate nutrition and cytokine stimulation.  Some T cells, with 
greater mitochondrial mass as a result of biogenesis or asymmetrical cell 
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division, are able to switch back to oxidative phosphorylation after being 
activated and become memory cells (Delmastro-Greenwood and Piganelli, 
2013).  Memory T cells have similar metabolism to naïve T cells, except that they 
have a higher T cell receptor (TCR) affinity.  Thus they can survive with less 
nutrients and cytokine stimulation, making them more advantageous (Delmastro-
Greenwood and Piganelli, 2013) (Figure 1). 
 
T Cell Differentiation 
T cells contain transmembrane proteins, like CD3 (part of the TCR), that 
transduce signals into the cell (Alberts, 2002; Cao et al., 2014).  CD3 proteins 
transmit signals to the cell when major histone complex (MHC) binds to the 
protein.  Helper T cells and cytotoxic T cells both contain a CD3 transmembrane 
protein.  Helper T cells contain a CD4 transmembrane protein as part of the TCR 
that binds to MHC class II proteins.  Cytotoxic T cells have a CD8 
transmembrane protein included in their TCR that binds to MHC class I proteins 
(Alberts, 2002).  When either MHC I or MHC II binds to the TCR, the binding acts 
through CD3 to trigger differentiation, metabolic reprogramming, proliferation, 
and growth (Cao et al., 2014). 
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Figure 1. The life cycle of T cells.  
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Cytotoxic T Cells 
Cytotoxic T cells (CTLs) destroy cells that have been infected by viruses 
and intracellular infections (Cao et al., 2014; Janeway et al., 2001; Masopust et 
al., 2007).  CTLs identify parts of the virus or bacteria on the infected cell 
membrane (Immune System T Cell, 2008) and then kill the infected cell by 
inducing apoptosis either by the release of granules or by the expression of the 
Fas ligand (Henkart and Catalfamo, 2004; Janeway et al., 2001).  CTLs release 
granules containing a variety of different substances that enter the targeted cell 
and induce apoptosis (Henkart and Catalfamo, 2014).  The other way that CTLs 
kill infected cells is by using the Fas ligand located on their membrane.  If the 
infected cell has CD95, or Fas receptor on its surface, the binding of CTL Fas 
ligand can induce apoptosis of the infected cell (Henkart and Catalfamo, 2014).  
CTLs can also secret cytokines that directly damage the infected cell or inhibit 
replication of microbes (Henkart and Catalfamo, 2004).  Activated CTLs have a 
highly glycolytic metabolism (Cao et al., 2014).  When first activated, CTLs have 
a faster rate of growth and proliferation than helper T cells (discussed in the next 
section) (Cao et al., 2014).  CTLs also have a higher rate of glycolysis compared 
with helper T cells following activation (Cao et al., 2014).  
CTLs are divided into subpopulations dependent on their surface markers.  
There are four subpopulations: CD27, CD28, CCR7, and CD62L (Henkart and 
Catalfamo, 2004). 
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Helper T Cells 
Helper T cells fight bacterial and fungal infections as well as activate many 
different types of cells, including B lymphocytes and CTLs, and regulate the 
immune response (Cao et al., 2014; Luckheeram et al., 2012).  There are two 
main types of helper T cells: Th helper cells and T regulatory cells (Tregs).   
When activated, Th helper cells have a highly glycolytic metabolism and 
an increased rate of oxidative metabolism.  Th helper cells have increased 
oxidative phosphorylation, higher mitochondrial mass, more activity, and greater 
maximal respiratory capacity compared with CTLs (Cao et al., 2014).  Th helper 
cells are divided into subsets which include Th1, Th2, and Th17.  The function of 
Th1 cells is to eliminate intracellular pathogens (Luckheeram et al., 2012).  The 
immune response of Th2 cells is to attack extracellular parasites (Luckheeram et 
al., 2012), and the immune response of Th17 cells is against extracellular 
bacteria and fungi (Luckheeram et al., 2012). 
After an immune response, Tregs, a type of CD4+ helper T cell, suppress 
the immune response through negative regulation.  This is done to protect 
against immunopathology (Luckheeram et al., 2012).  Unlike Th helper cells, 
activated Tregs have a primarily aerobic metabolism with high rates of fatty acid 
oxidation and low rates of glucose uptake (Delmastro-Greenwood and Piganelli, 
2013).  Also, unlike Th helper cells, lymphocytes differentiate into Tregs in the 
thymus (Luckheeram et al., 2012). 
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Aerobic Metabolism 
 In humans, oxidative phosphorylation is the main way to produce ATP in 
aerobic cellular respiration (Delmastro-Greenwood and Piganelli, 2013).  During 
aerobic respiration, cells oxidize glucose, fatty acids, and amino acids into acetyl 
coenzyme A (acetyl-CoA) (Delmastro-Greenwood and Piganelli, 2013).  During 
aerobic metabolism, glucose turns into pyruvate.  Pyruvate is converted into 
acetyl-CoA by a reaction catalyzed by pyruvate dehydrogenase (PDH) and its 
cofactor, thiamine (Koukourakis et al., 2005; Manzetti et al., 2014).  Acetyl-CoA 
enters the tricarboxylic acid cycle (TCA), and intermediates nicotinamide adenine 
dinucleotide (NAD+) and flavin adenine dinucleotide (FAD) are reduced.  The 
intermediate products of the TCA are nicotinamide adenine dinucleotide reduced 
(NADH) and flavin adenine dinucleotide reduced (FADH2).  NADH and FADH2 
enter the electron transport chain where they produce adenosine triphosphate 
(ATP) using oxidative phosphorylation.  Oxygen is required for this process 
(Delmastro-Greenwood and Piganelli, 2013). 
 The electron transport chain also creates reactive oxygen species (ROS).  
At high levels, ROS cause oxidative stress and damage molecules in the body 
(Delmastro-Greenwood and Piganelli, 2013). 
 
Anaerobic Metabolism 
The metabolism of activated T cells changes from aerobic to anaerobic.  
Lymphocytes switch from primarily relying on oxidative phosphorylation to relying 
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on glycolysis.  Glycolysis is a non-oxidative branch of glucose catabolism and is 
therefore anaerobic (Verbist et al., 2012).  In anaerobic metabolism, glucose is 
broken down into pyruvate as it is in aerobic metabolism.  However, instead of 
becoming acetyl-CoA, pyruvate is turned into lactate, NAD+, and ATP (Figure 2) 
(Delmastro-Greenwood and Piganelli, 2013).  While anaerobic metabolism is less 
efficient in producing ATP per glucose molecule, it is thought that glycolysis, 
which produces ATP at a faster rate than oxidative phosphorylation, is needed 
for the energy demands of proliferating cells (Delmastro-Greenwood and 
Piganelli, 2013; Maciolek et al., 2014; Verbist et al., 2012).  Glycolysis also 
produces important intermediates, like ribose-5-phosphate and glycine, for 
activated cells.  In addition, glycolysis may be an adaptive advantage over 
oxidative phosphorylation, since high rates of oxidative phosphorylation lead to 
high levels of ROS which damage cells (Verbist et al., 2012). 
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Figure 2. Differences in anaerobic and aerobic metabolism.  
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Current Research 
 There are a few current explanations for immunosuppression after a 
cardiac arrest.  Gu et al. (2013) proposed that patients experience a period of 
immunosuppression after a cardiac arrest because of an imbalance in the ratio of 
Th1 to Th2 T cells.  They believed that the imbalance is due to the oxygen debt 
created during the cardiac arrest, which causes endothelial activation of cytokine 
releases.  Gu and coworkers proved that there is an imbalance in the ratio of Th1 
and Th2 cells after a cardiac arrest by using a porcine model and measuring the 
transcription factors responsible for Th1 and Th2 cell differentiation.  They 
suggested that this imbalance contributes to the immune dysfunction post-
cardiac arrest (Gu et al., 2013). 
 Another study by Gu et al. (2014) proposed that reperfusion after a 
cardiac arrest causes lymphocyte apoptosis.  Their study examined the spleens 
in post-cardiac arrest porcine models and found lymphocyte apoptosis.  The 
researchers attributed this finding to the post-cardiac arrest inflammatory 
response, which causes the lymphocyte apoptosis pathway to activate.  They 
proposed that with fewer lymphocytes, the body has a decreased immune 
function (Gu et al., 2014). 
 Zhang et al. (2014) studied post-cardiac arrest hyperimmune response in 
a porcine model.  They attributed the immune dysregulation from increased 
cytokine release as a result of global ischemia.  The researchers proposed using 
Shen-Fu injection (SFI) to treat the cytokine dysregulation after a cardiac arrest.  
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They showed that SFI promotes immune system recovery by increasing anti-
inflammatory cytokines and decreasing proinflammatory cytokines (Zhang et al., 
2014). 
 
Specific Aims and Objectives 
The goal of this study is to characterize the immune system of post-
cardiac arrest patients.  Specifically, the objectives are: 
1. To determine the time period after the occurrence of a cardiac arrest 
that a patient acquires an infection, and to characterize the most 
common types of infections. 
2. To compare in vitro the cellular oxygen consumption of immune cells 
post-cardiac arrest with healthy controls, and to determine if there is a 
change in cellular metabolism post-cardiac arrest. 
3. To measure in vitro the cell proliferation and ATP production of T cells 
post-cardiac arrest. 
Characterization of post-cardiac arrest immunosuppression will provide us 
with insight into how to alter T cell metabolism and potentially manipulate its 
function.  This knowledge will help us develop the capability to dampen the 
hyperimmune response immediately following a cardiac arrest and to decrease 
the severity of the immunosuppression period. 
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METHODS 
 
 This study was done in three parts. For the first part, we performed a 
retrospective chart review of cardiac arrest patients to determine relevant 
statistics including (a) the time period after a cardiac arrest when patients 
acquired their first infection and (b) the types of infections that were most 
common.  In the second part, we compared the oxygen consumption rates of 
peripheral blood mononuclear cells (PBMCs) from cardiac arrest patients and 
healthy controls.  We also examined the effect of thiamine on respiration results 
for the cardiac arrest patients.  Lastly, we tested the blood of cardiac arrest 
patients after the arrest and healthy controls to determine T cell proliferation and 
ATP production.  We also evaluated these parameters by adding 
phytohemagglutinin (PHA) to the T cell samples. 
 
Retrospective Chart Review 
 We retrospectively reviewed 170 cardiac arrest patient charts (January 
2008 to November 2014) from Beth Israel Deaconess Medical Center (Boston, 
MA).  Patients had to meet the following criteria to be included in our study: 
1. Patient suffered an in-hospital or out-of-hospital cardiac arrest. 
2. Patient had return of spontaneous circulation post-cardiac arrest. 
3. Patient had cardiopulmonary resuscitation (CPR) performed during his 
or her cardiac arrest.  
4. Patient was at least 18 years old at the time of the arrest. 
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We recorded the following information by reviewing the patient’s discharge 
summary note and microbiology culture results: 
1. Patient’s last name 
2. Patient’s medical record number 
3. Patient’s age at the time of the cardiac arrest 
4. Arrest location: inside or outside a hospital 
5. Date of the cardiac arrest 
6. Patient’s hospital disposition 
7. Patient’s discharge date 
8. Patient’s Acute Physiology and Chronic Health Evaluation II (APACHE 
II) score on admission.  The APACHE II score (0-71) indicates the 
severity of a patient’s disease (Knaus et al., 1985).  
9. Patient’s Glasgow Coma Scale (GCS) score on admission.  The GCS 
score (3-15) indicates the patient’s level of consciousness (Teasdale et 
al., 2014).  
10. Presence of an infection prior to the arrest and the diagnosis of the 
infection 
11. Date of a positive culture prior to the arrest 
12. Results of the positive culture prior to the arrest 
13. Diagnosis of infection prior to the arrest 
14. Date of the first positive culture post-cardiac arrest 
15. Results of first positive culture post-cardiac arrest 
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16. Date of the second positive culture post arrest 
17. Results of second positive culture post-cardiac arrest 
18. Diagnoses of infection upon discharge 
From this information we calculated: 
1. The length of time in days from the cardiac arrest to the first positive 
culture. 2. The length of time in days from the cardiac arrest to hospital discharge 
or death.	  	  
Prospective T Cell Oxygen Consumption 
 Blood was drawn from five post-cardiac arrest patients 24 to 48 hours 
after their arrest.  These patients met the following criteria: 
1. Patient suffered an in-hospital or out-of-hospital cardiac arrest.  
2. Patient had return of spontaneous circulation post-cardiac arrest. 
3. Patient had CPR performed during his or her cardiac arrest.  
4. Patient was at least 18 years old at the time of the arrest.  
 Blood was also drawn from five healthy individuals to be used as the 
control group.  Control group individuals were at least 18 years old. 
Oxygen consumption rates of PBMCs were determined using an XFe96 
Analyzer (Seahorse Bioscience, North Billerica, MA).  PBMCs were isolated from 
blood samples by spinning the blood down with a centrifuge.  The plasma was 
removed, and a Ficoll-Paque solution (1.077 g/ml; GE Healthcare, Uppsala, 
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Sweden) was added for density gradient centrifugation.  After being spun down 
for a second time, the middle layer containing the PBMCs was extracted and 
placed in a separate tube. PMBCs were then seeded (500,000 cells per well) into 
Seahorse 96-well XF cell culture microplates.  Depending on the amount of blood 
provided by the patient or control, each sample was seeded into three to five 
wells.  Phosphate-buffered saline or phosphate-buffered saline with thiamine (1 
µg/mL) was added to some of the wells.  The plates rested at room temperature 
for one hour and were incubated overnight.  Cells were then washed with 
Seahorse XF Cell Mito Stress Test Assay Medium.  The plates were placed in a 
37 °C incubator without carbon dioxide for one hour.   
Each plate was then loaded into the XFe96 Analyzer, and oxygen 
consumption rates were measured following the manufacturer’s protocols.  The 
XF Cell Mito Stress Test targeted components of the electron transport chain to 
determine different parameters of cellular oxygen consumption, including basal 
respiration rate and maximum respiration rate.  Three different compounds—
oligomycin, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), and 
a mixture of rotenone and antimycin A—were added sequentially to the samples 
in the XFe96 Analyzer.  Oligomycin targeted complex V of the electron transport 
chain, ATP synthase, and caused a decrease in the oxygen consumption rate.  
FCCP targeted the inner mitochondrial membrane (mimicking an energy 
demand) and increased the oxygen consumption rate.  Finally, rotenone targeted 
complex I in the electron transport chain and antimycin A targeted complex III in 
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the electron transport chain, causing the oxygen consumption rate to decrease to 
a level representing non-mitochondrial respiration.  
Basal respiration was defined as the oxygen consumption rate of the cells 
under baseline conditions.  The basal oxygen consumption rate was measured 
by the XFe96 Analyzer as the oxygen consumption rate before oligomycin 
addition minus the non-mitochondrial respiration (oxygen consumption rate after 
rotenone and antimycin A addition).  The maximum respiration rate was defined 
as the highest rate of oxygen consumption obtainable by the cells.  The 
maximum oxygen consumption rate was measured by the XFe96 Analyzer as the 
oxygen consumption rate after FCCP addition minus the non-mitochondrial 
respiration (XF Cell Mito Stress Test Kit User Guide.pdf, n.d.). 
Thiamine was added to some of the samples to determine if it could 
increase the oxygen consumption rate by making the cells rely more on aerobic 
metabolism (see Figure 2). 
 
Prospective T Cell Proliferation and ATP Production  
 Blood was drawn from five post-cardiac arrest patients at 48 hours after 
their arrest.  Patients had to meet the following inclusion criteria: 
1. Patient suffered an in-hospital or out-of-hospital cardiac arrest. 
2. Patient had return of spontaneous circulation post-cardiac arrest.  
3. Patient had CPR performed during his or her cardiac arrest.  
4. Patient was at least 18 years old at the time of the arrest. 
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 Blood was drawn from eight healthy individuals for control samples.  
Control group individuals were at least 18 years old. 
 CD3+ T cells were isolated from blood samples using a magnetic-
activated cell sorting (MACS) separation protocol (Miltenyi Biotec, Auburn, CA).  
The final concentration of CD3+ T cells varied from sample to sample.  For 
cardiac arrest patients, concentrations of CD3+ T cells ranged from (1.5 to 2.0) x 
106 cells / 7 mL of blood.  For healthy controls, concentrations of CD3+ T cells 
ranged from (0.6 to 1.5) x 107 cells / 7 mL of blood. 
 T cell proliferation of both the cardiac arrest patients and the healthy 
individuals was measured using the Vybrant MTT Cell Proliferation Assay Kit 
(Molecular Probes, Eugene, OR).  In this colorimetric assay, MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), a water-soluble yellow 
dye, was reduced to an insoluble purple formazan by living cells.  Cells were 
seeded into wells and either PHA (16 μg/mL) or nothing was added to each 
well.  This was followed by the addition of 5 mg of MTT and 1 mL of phosphate-
buffered saline to the wells.  The microplate was incubated at 37 °C for four 
hours, and then 1 g of sodium dodecyl sulfate and 10 mL of 0.01 M hydrogen 
chloride were added to the wells.  The microplate was incubated in a 37 °C 
humidified chamber for another four hours.  The plate was then placed into the 
SpectraMax 190 UV-Vis Microplate Spectrophotometer (Molecular Devices, 
Sunnyvale, CA), and the absorbance was read at 570 nm. 
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 T cell ATP production was assessed using the CellTiter-Glo Luminescent 
Cell Viability Assay G7571 (Promega, Madison, WI).  In this protocol, CellTiter-
Glo Reagent was added to the cells, resulting in cell lysis and generation of a 
luminescent signal (luciferase reaction) proportional to the amount of ATP 
present in the cells.  CD3+ T cells were first seeded into plates.  PHA (16 µg/mL) 
was added to some of the wells and incubated overnight.  After incubation, plates 
were left at room temperature for thirty minutes.  CellTiter-Glo Reagent was 
made from 10 mL of CellTiter-Glo Buffer and 0.01 mL of CellTiter-Glo Substrate.  
The CellTiter-Glo Reagent (100 µL ) was then added to the wells, and the plates 
were incubated at room temperature for 10 minutes.  Afterward, luminescence 
was recorded using a SpectraMax M5 (Molecular Devices, Sunnyvale, CA). 
PHA was utilized in both assays because it is a non-specific mitogenic 
lectin which binds to cell membranes and stimulates proliferation in T cells 
(Martin-Chouly et al., 2011). 
  
Statistics 
For the chart review, we used a Mann-Whitney test to determine the 
statistical significance between the length of time from cardiac arrest to first 
positive culture for survivors and non-survivors.  Statistical significance was 
defined as p < 0.05.  
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For the oxygen consumption rate, statistical significance was determined 
using a one-way ANOVA test.  Statistical significance was defined as p < 0.05.  
Results are expressed as mean ± standard error. 
 For proliferation and ATP production, statistical significance was 
determined between the healthy control group and the cardiac arrest group using 
a t-test for two independent means.  A t-test for dependent means was used to 
determine the statistical significance when PHA was added.  Statistical 
significance was defined as p < 0.05.  Results are expressed as median values 
because the sample sizes were small. 
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RESULTS 
 
Retrospective Chart Review 
 We reviewed the charts of 170 cardiac arrest patients (Tables 1 and 2).  
The average age of these patients was 64.3 years old.  They had an average 
APACHE II score of 26.9 and an average GCS score of 4.7 on admission.  A 
total of 105 cardiac arrests (62%) took place outside the hospital, while 65 (38%) 
took place in the hospital. 
 In 42% of the patients there was at least one incidence of infection post-
cardiac arrest, and in 7% of the group there was evidence of multiple infections.  
Fifty-six patients had pneumonia, and 16 patients had urinary tract infections.  
Prior to their cardiac arrest, 25% of the patients had infections (Table 2). 
 On average, 4.2 days elapsed between the time of the cardiac arrest and 
the first incidence of a positive culture. Post-cardiac arrest patients who survived 
to hospital discharge and acquired an infection had a first positive culture 5.3 
days after their arrest.  Post-cardiac arrest patients who did not survive to 
hospital discharge and acquired an infection had a first positive culture 2.6 days 
after their arrest.  The difference in length of time from cardiac arrest to first 
positive culture between survivors and non-survivors was statistically significant 
(p = 0.04).  The average length of time until hospital discharge or death was 8.5 
days after the cardiac arrest (Table 1).   
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   Cardiac	  Arrest	  
(n	  =	  170)	  
Age	  in	  years	   64.3	  
APACHE	  II	  on	  admission	   26.9	  
GCS	  on	  admission	   4.7	  
Days	  until	  discharge	  or	  death	   8.5	  
Days	  elapsed	  to	  first	  positive	  culture	   4.2	  
Days	  to	  first	  positive	  culture	  of	  survivors	   5.3	  
Days	  to	  first	  positive	  culture	  of	  non-­‐survivors	   2.6	  
 
Table 1. Summary of general descriptors from chart review of the cardiac 
arrest patients.  Tabulated results are from 170 cardiac arrest patient charts 
(January 2008 to November 2014) from Beth Israel Deaconess Medical Center 
(Boston, MA).  APACHE II = Acute Physiology and Chronic Health Evaluation II 
score; GCS = Glasgow Coma Scale score. 
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Number	  of	  Patients	   Percentage	  of	  Total	  Patients	  
Arrest	  Location	  
	   	  	  	  	  	  	  Out-­‐of-­‐hospital	  cardiac	  arrest	   105	   61.8%	  
	  	  	  	  	  In-­‐hospital	  cardiac	  arrest	   65	   38.2%	  
Incidence	  of	  at	  least	  one	  infection	   72	   42.4%	  
Discharge	  diagnosis	  
	   	  	  	  	  	  	  Pneumonia	   56	   32.9%	  
	  	  	  	  	  Urinary	  tract	  infection	   16	   9.4%	  
	  	  	  	  	  Other	   10	   5.9%	  
	  	  	  	  	  Multiple	   12	   7.1%	  
	  	  	  	  	  No	  diagnosis	  of	  infection	   98	   57.6%	  
Infections	  prior	  to	  arrest	   42	   24.7%	  
 
Table 2. Summary of patient numbers from chart review of the cardiac 
arrest patients.  Tabulated results are from 170 cardiac arrest patient charts 
(January 2008 to November 2014) from Beth Israel Deaconess Medical Center 
(Boston, MA).   
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Prospective T Cell Oxygen Consumption 
 We obtained the basal oxygen consumption rates for five healthy controls 
and five cardiac arrest patients (Figure 3).  Healthy controls had a basal 
respiration rate (mean ± SE) of 24 ± 2 pmol/min.  Cardiac arrest patients had a 
basal respiration rate of 18 ± 1 pmol/min.  There was no statistically significant 
difference between these two groups (p = 0.06). 
 The maximum oxygen consumption rates were measured for both healthy 
controls and cardiac arrest patients (Figure 4).  Healthy controls had a maximum 
respiration rate of 54 ± 2 pmol/min.  Cardiac arrest patients had a maximum 
respiration rate of 40 ± 3 pmol/min.  The difference between the maximum 
respiratory oxygen consumption rates of the cardiac arrest patients and the 
healthy controls was statistically significant (p = 0.009). 
 Basal respiration rates were measured when thiamine was added to the 
PBMCs of cardiac arrest patients (Figure 5).  The basal oxygen consumption rate 
for cardiac arrest patients with thiamine was 26 ± 2 pmol/min.  There was a 
statistically significant difference between the basal respiration rates of PBMCs 
with and without thiamine from cardiac arrest patients (p = 0.001).   
 Maximum respiration rates of PBMCs with added thiamine were also 
measured (Figure 6).  The maximum respiration rate for cardiac arrest patients 
with thiamine was 56 ± 4 pmol/min.  There was a statistically significant 
difference between the maximun oxygen consumption rates of PBMCs with and 
without thiamine from cardiac arrest patients (p = 0.01).  
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Figure 3. Basal respiration rates in controls and cardiac arrest patients.  
There is no statistical difference between the basal respiration oxygen 
consumption rates of PBMCs from healthy controls and cardiac arrest patients (p 
= 0.06).  Values are mean ± SE; n = 5. 
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Figure 4. Maximum respiration rates in controls and cardiac arrest patients.  
The maximum respiration oxygen consumption rate of PBMCs is lower in cardiac 
arrest patients than in healthy controls (p = 0.009).  Values are mean ± SE; n = 5. 
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Figure 5. Effect of thiamine on basal respiration rates in cardiac arrest 
patients.  The basal respiration oxygen consumption rate of PBMCs from 
cardiac arrest patients is higher with added thiamine (p = 0.001).  Values are 
mean ± SE; n = 5. 
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Figure 6. Effect of thiamine on maximum respiration rates in cardiac arrest 
patients.  The maximum respiration oxygen consumption rate of PBMCs from 
cardiac arrest patients is higher with added thiamine (p = 0.01).  Values are 
mean ± SE; n = 5. 
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Prospective T Cell Proliferation and ATP Production 
 We measured ATP production in CD3+ T cells from healthy controls and 
cardiac arrest patients 48 hours after the arrest (Figure 7).  The median baseline 
ATP production for eight healthy controls was 720 ng/mL.  The median baseline 
ATP production for five cardiac arrest patients was 418 ng/mL.  There was no 
statistically significant difference between these two groups (p = 0.44). 
 We also measured ATP production in CD3+ T cells when PHA was added 
to the cells.  The change from baseline ATP production was determined for both 
healthy controls and cardiac arrest patients (Figure 8).  The median ATP 
production with PHA showed a 127% increase above baseline for CD3+ T cells 
from eight healthy controls.  The CD3+ T cells from five cardiac arrest patients 
had a median ATP production with PHA that was 120% greater than baseline.  
No statistically significant difference was found between the two groups (p = 
0.30). 
 In addition to measuring ATP production, we measured the proliferation of 
CD3+ T cells with PHA in healthy controls and cardiac arrest patients.  The 
change from baseline cell proliferation was calculated for both groups (Figure 9).  
In five healthy controls, the median increase in proliferation was 105% above 
baseline when PHA was added to the CD3+ T cells.  For three cardiac arrest 
patients, a median proliferation increase of 106% above baseline was observed 
with the addition of PHA.  There was no statistically significant difference 
between these two groups (p = 0.90).  
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Figure 7. Baseline ATP production in controls and cardiac arrest patients.  
There is no statistical difference between the ATP production in CD3+ T cells 
from healthy controls and cardiac arrest patients 48 hours after the arrest (p = 
0.44).  Values are median; n = 5-8. 
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Figure 8. Effect of PHA on ATP production in controls and cardiac arrest 
patients.  ATP production in CD3+ T cells increases above baseline production 
when PHA is added to healthy controls and cardiac arrest patients 48 hours after 
the arrest.  There is no statistical difference between the changes in both groups 
(p = 0.30).  Values are median; n = 5-8. 
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Figure 9. Effect of PHA on cell proliferation in controls and cardiac arrest 
patients.  Proliferation of CD3+ T cells increases above baseline proliferation 
when PHA is added to healthy controls and cardiac arrest patients 48 hours after 
the arrest.  Baseline proliferation rate is 100%.  There is no statistical difference 
between the changes in both groups (p = 0.90).  Values are median; n = 3-5 
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DISCUSSION 
 
 Many patients suffer from infections post-cardiac arrest.  The purpose of 
this study was to characterize immunosuppression and T cell metabolism in post-
cardiac arrest patients.  The major findings of this study were as follows: (1) 42% 
of cardiac arrest patients who had return of spontaneous circulation acquired an 
infection, (2) infections occurred an average of 4 days after the cardiac arrest, 
with pneumonia and urinary tract infections the most common, (3) PBMCs of 
cardiac arrest patients had lower rates of maximum oxygen consumption 
compared with healthy controls, and (4) thiamine increased the basal and 
maximum oxygen consumption rates of PBMCs from cardiac arrest patients. 
 
Retrospective Chart Review 
 Of the 170 cardiac arrest patients we reviewed, 42% of them had at least 
one incidence of infection post arrest.  This finding suggests that cardiac arrest 
patients suffer from a compromised immune system after an arrest.  Moreover, 
this result emphasizes the importance of more intensive research in the area of 
post-cardiac arrest treatment. 
 Cardiac arrest patients had a first positive blood culture 4 days after their 
arrest.  The most prominent diagnosis was pneumonia, followed by urinary tract 
infections.  These results imply that the period of immunosuppression started 
sometime within 4 days of the cardiac arrest.  Post-cardiac arrest patients who 
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survived to hospital discharge and acquired an infection had a first positive 
culture 3 days later than non-survivor cardiac arrest patients who acquired an 
infection.  This finding suggests that patients with stronger immune systems, who 
can sustain a longer period of time before acquiring an infection, have a higher 
survival rate.   
 
Prospective T Cell Oxygen Consumption 
 We measured the PBMC oxygen consumption rates of cardiac arrest 
patients 24 to 48 hours after their cardiac arrest compared with healthy control 
patients.  PBMCs include T cells as well as B cells and monocytes.  Like T cells, 
B cells and monocytes switch to increased glycolysis utilization when they are 
activated (Delmastro-Greenwood and Piganelli, 2013; Dietl et al, 2010; Marsin et 
al., 2002).  Compared with healthy controls, the PBMCs of cardiac arrest patients 
showed a significant decrease in the maximum respiration oxygen consumption 
rate.  These findings suggest that after a cardiac arrest, PBMCs switch to a more 
anaerobic metabolism compared with their healthy counterparts.  Since PBMCs 
change metabolism from primarily aerobic to primarily anaerobic when they are 
activated, this drop in maximum respiration may indicate that PBMCs are 
activated post-cardiac arrest.  It is also possible that these findings reflect PMBC 
death post-cardiac arrest, a situation that leads to a decreased number of cells 
and lower oxygen consumption. 
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 Thiamine significantly increased the basal and maximum oxygen 
consumption rates of PBMCs in cardiac arrest patients compared with their 
baseline values.  This finding suggests that thiamine may be able to increase the 
aerobic metabolism of these cells and potentially decrease the use of the 
anaerobic pathway. 
 
Prospective T Cell Proliferation and ATP Production 
 We measured T cell proliferation and ATP production in healthy controls 
and cardiac arrest patients 48 hours after their arrest.  The overall results were 
inconclusive.  In both cardiac arrest patients and healthy controls, the CD3+ T 
cells had similar baseline ATP production, and when stimulated by PHA, they 
had similar increases in ATP production and in cellular proliferation.  The lack of 
statistical significance between the cardiac arrest patients and the healthy 
controls may be due to the small sample size of each group. 
 
Future Research 
More research needs to be done on this subject because a high 
percentage of cardiac arrest patients acquire an infection post-cardiac arrest with 
current treatments.  A future study should include more patients and more time 
points after the cardiac arrest to draw blood for assessing oxygen consumption, 
ATP production, and cellular proliferation.  It would also be helpful to isolate T 
cells from the PBMC mixture in order to more conclusively determine their 
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oxygen consumption rate post arrest.  This would lead to a clearer picture of a 
hyperimmune response and immunosuppression timeline. 
A future study should also continue to investigate the effects of thiamine 
on T cell metabolism in order to gain more conclusive results.  There is a 
possibility that by giving cardiac arrest patients thiamine post arrest, we could 
change the T cell metabolism from primarily anaerobic to primarily aerobic.  This 
switch in metabolism would decrease the severity of the hyperimmune response 
by decreasing the number of T cells activated immediately post-cardiac arrest.  
This action would in turn decrease immunosuppression of post-cardiac arrest 
patients and potentially lead to a decreased infection rate. 
 
Conclusion 
 Because many cardiac arrest patients suffer from immunosuppression 
post arrest, there is a need for ongoing research on this issue.  Our study 
showed that there is a decrease in the oxygen consumption rate of PMBCs post-
cardiac arrest.  Our results also indicated that thiamine increases the oxygen 
consumption rate in PBMCs of cardiac arrest patients.  More research is required 
to determine whether cardiac arrest patients and healthy controls have 
differences in CD3+ T cell proliferation and ATP production. 
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